• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVASCULAR, INC. OVATION IX ABDOMINAL STENT GRAFT SYSTEM; ENDOVASCULAR GRAFT, ABDOMINAL AORTIC ANEURYSM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVASCULAR, INC. OVATION IX ABDOMINAL STENT GRAFT SYSTEM; ENDOVASCULAR GRAFT, ABDOMINAL AORTIC ANEURYSM Back to Search Results
Model Number TV-AB3480-J
Device Problems Material Invagination (1336); Off-Label Use (1494)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 04/28/2017
Event Type  Injury  
Manufacturer Narrative
Device remains implanted.
 
Event Description
An ovation ix abdominal stent graft system was implanted to treat an abdominal aortic aneurysm.The initial procedure went without issue and the post-operative ct showed no signs of a type 1a endoleak.One month post-op, the patient returned for a routine follow-up where physician observed a type 1a endoleak.A re-intervention was done where physician implanted a palmaz stent and successfully resolved the type 1a endoleak.As of the date of this report, there have been no additional patient sequelae reported.
 
Manufacturer Narrative
Based on the description of the event and provided medical records, clinical assessment confirmed the reported events of the type ia endoleak, and secondary procedure.Additionally, clinical assessment identified type ii endoleaks at the ima and l4 lumbar artery, as well as infolding of the sealing ring.The most likely cause of the loss of seal is the infolding of the sealing ring in an angulated proximal neck (juxtarenal angulation of 77 degrees, off-label).There were no known procedure or user related issues or cautionary product use conditions related to this event.Associated clinical harms for this device included: type ia endoleak; secondary endovascular procedure of placing a self expanding stent across the sealing ring.The final patient disposition was discharged home on post operative day one in improved condition.There was no device related issue involving the type ii endoleak the cautionary product use conditions such as a patent ima and lumbar arteries, likely contributed to the clinical harm.The review of manufacturing lot confirmed all devices met specifications prior to release.No additional investigations of this reported complaint are planned.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX ABDOMINAL STENT GRAFT SYSTEM
Type of Device
ENDOVASCULAR GRAFT, ABDOMINAL AORTIC ANEURYSM
Manufacturer (Section D)
TRIVASCULAR, INC.
3910 brickway blvd.
santa rosa CA 95403
Manufacturer (Section G)
TRIVASCULAR, INC.
3910 brickway blvd.
santa rosa CA 95403
Manufacturer Contact
alexis weil
3910 brickway blvd.
santa rosa, CA 95403
MDR Report Key6594948
MDR Text Key76126525
Report Number3008011247-2017-00263
Device Sequence Number1
Product Code MIH
UDI-Device IdentifierM701TVAB3480J1
UDI-Public+M701TVAB3480J1/$$3200124FS092616153
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/31/2020
Device Model NumberTV-AB3480-J
Device Catalogue NumberTV-AB3480-J
Device Lot NumberFS092616-15
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/27/2017
Initial Date FDA Received05/26/2017
Supplement Dates Manufacturer Received07/03/2017
Supplement Dates FDA Received05/30/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/31/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-